Kao Corporation

Junko Suzuki

Akira Shimotoyodome

Tomohisa Ichiba

Hidenori Yorozu

Takatoshi Murase

Norihiro Tanaka

Noriyuki Yajima

Ichirou Tokimitsu

Narushi Takahashi

Nanami Takeno

Tomohito Mizuno

Shinichi Meguro

The present invention provides a method for preventing or ameliorating obesity, for inhibiting accumulation of visceral fat, for inhibiting accumulation of liver lipid, for preventing or ameliorating fatty liver, including using a material for a pharmaceutical product or food, which has inhibitory actions on body weight increase, accumulation of visceral fat and accumulation of liver lipid. The present invention is also directed to a method for preventing or ameliorating obesity, a method for inhibiting accumulation of visceral fat, a method for inhibiting accumulation of liver lipid, and a method for preventing or ameliorating fatty liver, which methods include administering potassium alginate to a subject in need thereof or having the subject take potassium alginate.

Agent for preventing or ameliorating obesity

The present invention provides a postprandial GIP secretion inhibitor comprising potassium alginate as an active ingredient. The postprandial GIP secretion inhibitor of the present invention is useful as a medicine or a food product. The present invention also provides use of potassium alginate for the manufacture of a postprandial GIP secretion inhibitor. The present invention also provides a method for inhibiting postprandial GIP secretion, which comprises administering potassium alginate to a subject in need thereof or causing a subject in need thereof to consume potassium alginate.

GIP secretion inhibitor

The present invention relates to a preventive/remedy for obesity, which has a hydroxypropylated starch as its active ingredient. Provided are materials for foods, drugs, etc. which can exhibit an effect of preventing/lessening the onset of various lifestyle related diseases, for example, an effect of preventing/ameliorating obesity, or preventing/ameliorating hyperlipidemia; have a high safety and a wide application range; and rarely damage their texture.

Preventive/remedy for obesity

The present invention provides a bubble bath composition containing (A) 10-30% by weight of a C.sub.8-18 alkylalkanolamide surfactant or a C.sub.8-18 alkyldimethylamino acetic acid betaine surfactant, (B) 5-20% by weight of an anionic surfactant, C.sub.8-18 alkyl (or polyether-type) sulfate, and (C) 20-80% by weight of a polyol, wherein the ratio by weight of component (A) to component (B) is greater than or equal to 1 and the composition has a viscosity of less than or equal to 1000 cp at 20.degree. C. This composition provides excellent foam producing ability and foam persistence, is readily dispersed in bath water, and imparts moistness to the skin after bathing. The composition of the invention is relaxation due to its rich foam and moisturizing sensation of the skin.

Bubble bath composition

Growing community of inventors

Haga-gun, Japan

Junko Suzuki